Given the specific inhibitory effects of VEGFA on tumor-reactive, cytotoxic CD8+ T cells (Gavalas et al., 2012; Kim et al., 2019), a VEGFA-trap directed to activated CD8+ T cells may improve antitumor T cell activities in VEGFA-rich TME. The gene discussed is VEGFA; the disease is neoplasm.